Iterion Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma (NCT05797805) | Iterion Therapeutics | 2023-09-13 |
| Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 (NCT03459469) | Iterion Therapeutics | 2018-07-15 |
Track Iterion Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.